Aiforia® Breast Cancer Suite

Diagnostics and imaging · by Aiforia Technologies Plc

An integrated AI suite for breast cancer diagnostics, consisting of several CE-IVD marked AI models and the Aiforia® Clinical Suite Viewer.

What it does

An integrated AI suite for breast cancer diagnostics, consisting of several CE-IVD marked AI models and the Aiforia® Clinical Suite Viewer. Includes the HER2 AI model which assists pathologists in accurately assessing HER2 status in breast cancer tissue samples.

  • Developing deep learning AI models for histological image analysis
  • Automating repetitive pathology image analysis tasks
  • Assisting pathologists in cancer diagnostics with CE-IVD marked AI models
  • Standardizing analysis and improving consistency in digital pathology workflows
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Pathologists, Medical scientists, Researchers, Healthcare providers and 1 more
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Aiforia Technologies Plc doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Aiforia Technologies Plc. Ask for audit reports before you buy.

  • HIPAACompliant
  • ISO 9001Certified

Reviews

No reviews yet

Reviews come from people who use Aiforia® Breast Cancer Suite at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Aiforia® Breast Cancer Suite